Deep Learning to Estimate Cardiovascular Risk From Chest Radiographs : A Risk Prediction Study
- PMID: 38527287
- DOI: 10.7326/M23-1898
Deep Learning to Estimate Cardiovascular Risk From Chest Radiographs : A Risk Prediction Study
Abstract
Background: Guidelines for primary prevention of atherosclerotic cardiovascular disease (ASCVD) recommend a risk calculator (ASCVD risk score) to estimate 10-year risk for major adverse cardiovascular events (MACE). Because the necessary inputs are often missing, complementary approaches for opportunistic risk assessment are desirable.
Objective: To develop and test a deep-learning model (CXR CVD-Risk) that estimates 10-year risk for MACE from a routine chest radiograph (CXR) and compare its performance with that of the traditional ASCVD risk score for implications for statin eligibility.
Design: Risk prediction study.
Setting: Outpatients potentially eligible for primary cardiovascular prevention.
Participants: The CXR CVD-Risk model was developed using data from a cancer screening trial. It was externally validated in 8869 outpatients with unknown ASCVD risk because of missing inputs to calculate the ASCVD risk score and in 2132 outpatients with known risk whose ASCVD risk score could be calculated.
Measurements: 10-year MACE predicted by CXR CVD-Risk versus the ASCVD risk score.
Results: Among 8869 outpatients with unknown ASCVD risk, those with a risk of 7.5% or higher as predicted by CXR CVD-Risk had higher 10-year risk for MACE after adjustment for risk factors (adjusted hazard ratio [HR], 1.73 [95% CI, 1.47 to 2.03]). In the additional 2132 outpatients with known ASCVD risk, CXR CVD-Risk predicted MACE beyond the traditional ASCVD risk score (adjusted HR, 1.88 [CI, 1.24 to 2.85]).
Limitation: Retrospective study design using electronic medical records.
Conclusion: On the basis of a single CXR, CXR CVD-Risk predicts 10-year MACE beyond the clinical standard and may help identify individuals at high risk whose ASCVD risk score cannot be calculated because of missing data.
Primary funding source: None.
Conflict of interest statement
Similar articles
-
Deep Learning Using Chest Radiographs to Identify High-Risk Smokers for Lung Cancer Screening Computed Tomography: Development and Validation of a Prediction Model.Ann Intern Med. 2020 Nov 3;173(9):704-713. doi: 10.7326/M20-1868. Epub 2020 Sep 1. Ann Intern Med. 2020. PMID: 32866413 Free PMC article.
-
Cardiovascular risk assessment using ASCVD risk score in fibromyalgia: a single-centre, retrospective study using "traditional" case control methodology and "novel" machine learning.Adv Rheumatol. 2021 Nov 27;61(1):72. doi: 10.1186/s42358-021-00229-w. Adv Rheumatol. 2021. PMID: 34838137
-
Risk factors for cardiovascular disease among individuals with hepatic steatosis.Hepatol Commun. 2022 Dec;6(12):3406-3420. doi: 10.1002/hep4.2090. Epub 2022 Oct 25. Hepatol Commun. 2022. PMID: 36281983 Free PMC article.
-
Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition.Curr Diab Rep. 2019 Jul 22;19(8):61. doi: 10.1007/s11892-019-1178-6. Curr Diab Rep. 2019. PMID: 31332544 Review.
-
Coronary artery calcium scoring for cardiovascular risk assessment in patients with inflammatory bowel disease.Am Heart J. 2023 Dec;266:120-127. doi: 10.1016/j.ahj.2023.08.011. Epub 2023 Aug 25. Am Heart J. 2023. PMID: 37634654 Review.
Cited by
-
Artificial Intelligence in Cardiovascular Disease Prevention: Is it Ready for Prime Time?Curr Atheroscler Rep. 2024 Jul;26(7):263-272. doi: 10.1007/s11883-024-01210-w. Epub 2024 May 23. Curr Atheroscler Rep. 2024. PMID: 38780665 Review.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical